Ajanta Pharma reports 7% fall in Q2 consolidated net profit

06 Nov 2019 Evaluate

Ajanta Pharma has reported results for second quarter ended September 30, 2019.

The company has reported a rise of 15.95% in its net profit at Rs 120.70 crore for the quarter under review as compared to Rs 104.10 crore for the same quarter in the previous year. Total income of the company increased by 24.17% at Rs 598.76 crore for Q2FY20 as compared Rs 482.22 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 7.20% in its net profit at Rs 116.36 crore for the quarter under review as compared to Rs 125.39 crore for the same quarter in the previous year. However, total income of the company increased by 17.28% at Rs 655.98 crore for Q2FY20 as compared Rs 559.35 crore for the corresponding quarter previous year.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×